11/21
08:27 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Mizuho from $19.00 to $22.00. They now have an "outperform" rating on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Mizuho from $19.00 to $22.00. They now have an "outperform" rating on the stock.
11/15
08:30 am
wve
Wave Life Sciences to Present at Jefferies London Healthcare Conference
Medium
Report
Wave Life Sciences to Present at Jefferies London Healthcare Conference
11/15
07:41 am
wve
Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 [Yahoo! Finance]
Medium
Report
Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 [Yahoo! Finance]
11/14
12:02 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/13
10:08 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
11/13
02:12 am
wve
WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Low
Report
WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
11/12
02:31 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Truist Financial Co. from $17.00 to $36.00. They now have a "buy" rating on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Truist Financial Co. from $17.00 to $36.00. They now have a "buy" rating on the stock.
11/12
07:30 am
wve
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
12:13 pm
wve
Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
Low
Report
Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
11/4
04:05 pm
wve
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
Low
Report
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
11/4
01:45 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at B. Riley from $19.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at B. Riley from $19.00 to $22.00. They now have a "buy" rating on the stock.
11/3
08:39 am
wve
Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. [Yahoo! Finance]
Low
Report
Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. [Yahoo! Finance]
10/31
10:42 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/30
04:51 pm
wve
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs [Yahoo! Finance]
Medium
Report
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs [Yahoo! Finance]
10/30
04:45 pm
wve
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
Medium
Report
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
10/23
01:12 pm
wve
What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Low
Report
What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
10/21
10:04 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $15.00. They now have a "sector perform" rating on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $15.00. They now have a "sector perform" rating on the stock.
10/17
12:23 pm
wve
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data [Yahoo! Finance]
Medium
Report
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data [Yahoo! Finance]
10/17
10:38 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at JPMorgan Chase & Co. from $13.00 to $17.00. They now have an "overweight" rating on the stock.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at JPMorgan Chase & Co. from $13.00 to $17.00. They now have an "overweight" rating on the stock.
10/17
09:31 am
wve
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? [Yahoo! Finance]
Low
Report
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? [Yahoo! Finance]
10/17
08:55 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/16
04:45 pm
wve
Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst [Seeking Alpha]
Low
Report
Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst [Seeking Alpha]
10/16
01:44 pm
wve
RNA-Editing Stocks Soar on Wave Life's Breakthrough Trial Data [Yahoo! Finance]
Low
Report
RNA-Editing Stocks Soar on Wave Life's Breakthrough Trial Data [Yahoo! Finance]
10/16
01:35 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Leerink Partners from $20.00 to $22.00. They now have an "outperform" rating on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Leerink Partners from $20.00 to $22.00. They now have an "outperform" rating on the stock.
10/16
01:34 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.